Anthropic’s $1.5B copyright settlement: should authors opt in, opt out, or object?

If you’re an author or rights holder wondering what the delayed approval of Anthropic’s reported $1.5 billion copyright settlement means for you, the short answer is: nothing pays out yet, deadlines may shift, and you still have three choices—file a claim, opt out to sue on your own, or object to seek changes—once the court finalizes the notice plan. Your best path depends on your catalog size, registration status, appetite for litigation risk, and how the court ultimately rules on attorney fees and allocation.

The judge’s pause signals increased scrutiny—especially over whether the deal is fair to class members and whether the attorneys’ fees are proportionate. That’s common in very large class actions. Expect more briefing, possible tweaks to the notice and distribution plan, and a new timeline. Meanwhile, start gathering records, confirm whether your works were likely used in training, and map out your decision framework so you can act quickly when updated court papers land.

What changed—and why it matters

• The court did not immediately approve the settlement. In large class actions, courts typically grant “preliminary approval” first, triggering official notices to class members, followed by a “final approval” (or “fairness”) hearing. A delay suggests the judge wants more clarity on fairness, scope, fees, or administration before greenlighting notice.
• Fee scrutiny is normal. Percentage-of-fund fees around 20%–33% are common in mega-fund cases, but judges often apply extra scrutiny to prevent disproportionate attorney compensation relative to class relief. If fees are cut, more money may flow to class members.
• Practical effect for you: no immediate action deadlines apply until the court sets them. But preparation now (catalog audit, evidence, tax info) avoids scrambles later.

Who this guide is for

• Book authors (traditionally published or indie/self-published)
• Journalists and essayists with substantial online archives
• Publishers, imprints, and literary estates
• Translators, anthologists, and rights managers with derivative or collective rights
• Agents and lawyers advising talent and catalog owners
• Platform operators hosting user-generated written works that may have been scraped

A quick decision framework: opt in, opt out, or object?

You’ll eventually see a court-approved notice describing:

• The class definition (who’s included)
• How to file a claim (and by when)
• How to opt out (and by when)
• How to object (and by when)

Use this high-level decision tree:

• Choose to file a claim (opt in) if:

  • You want predictable cash relief without multi-year litigation.
  • Your works weren’t all timely registered, narrowing statutory damage leverage.
  • You prefer not to finance or endure discovery-heavy litigation.

• Choose to opt out if:

  • You hold a large, valuable, and well-registered catalog (or can show willful use) that could command higher damages individually.
  • You want to pursue injunctive or licensing terms different from the class deal.
  • You can tolerate cost, time, and risk of suing separately.

• Choose to object (while staying in) if:

  • You think the deal needs fixes (e.g., allocation, future-use protections, fee size) but you still want to participate if it’s improved.
  • You want the court to adjust terms without giving up your claim.

Note: Objecting preserves your ability to receive benefits if the deal is approved; opting out removes you from the class entirely.

What to look for in the final settlement papers

While the exact terms may still evolve, scrutinize these elements when the court circulates updated documents:

1. Eligibility and class scope

   • Does the class include only text authors, or also publishers and other rightsholders with assignments? What about journalists, bloggers, forum posters, or translators?
   • Are foreign rightsholders included? If so, under what law and notice regime?

2. Types of relief

   • Cash relief: Is it a common fund with pro rata distribution, a claims-made structure, or a hybrid? Are there tiers (e.g., books vs. shorter works), caps, or minimums?
   • Prospective relief: Are there commitments around training data, licensing, exclusion/opt-out mechanisms for future training, dataset provenance records, or output filtering improvements?

3. Allocation methodology

   • How are points assigned? Possible factors: number of works, length, format, registration status, publication date, market value proxies, or evidence of specific ingestion.
   • Is there a claims audit or sampling approach to verify submissions without making filing overly burdensome?

4. Attorney fees and administration costs

   • Percentage-of-fund vs. lodestar (hours x rate) with multiplier. Are there “clear sailing” or “kicker” clauses (red flags courts scrutinize)?
   • Transparency: Will detailed time records, cost ledgers, and administrator budgets be filed publicly?

5. Notice and due process

   • Is the notice understandable, reaching both traditionally published and indie creators? Are multiple channels used (email, postal, guilds, PROs, social, translator associations)?
   • Are deadlines reasonable, with accommodations for international and disabled claimants?

6. Release and carve-outs

   • What claims are released (training, dataset creation, model weights, outputs, attribution)? For which time period? Are moral rights or future derivative claims carved out where applicable?

7. Dispute and audit mechanisms

   • If your point total or claim is downgraded, how do you appeal? Is there an ombuds or special master?

Pros and cons of participating as proposed

Pros

• Faster, guaranteed path to some compensation without proving individualized infringement.
• Potential improvements to transparency and opt-out tools for future model training (if included).
• Pooled negotiation power that’s difficult to match as a solo plaintiff.

Cons

• Per-work payouts may be modest in a mega-class, especially if claims are broad and fees/administration are large.
• You’ll release certain claims—possibly including future ones—limiting your ability to sue later over the same conduct.
• Injunctive relief may be less granular than what a large publisher or celebrity author could secure individually.

Should you opt out? Scenarios to consider

Opt out makes sense more often when:

• You have a large, valuable, and registered catalog and can credibly argue willful infringement at scale.
• You already preserved evidence of dataset inclusion (e.g., your books appear in known training indexes, web scrapes, or leak analyses), strengthening causation.
• You can tolerate litigation costs, discovery, and time to verdict/settlement.

Staying in the class may be better if:

• Your catalog is smaller, less registered, or harder to prove as ingested.
• You primarily want quick compensation and a standardized path to prospective safeguards.
• You lack resources or appetite for years of litigation and appeals.

Hybrid approach some rightsholders take:

• Large houses or estates opt out for top-tier works and keep lesser-value titles in the class to capture baseline relief.
• Coordinate with your agent or counsel to avoid double-recovery issues and ensure chain-of-title clarity.

How to prepare now (even before new deadlines drop)

• Inventory your catalog

  • List titles, publication dates, ISBNs/DOIs/URLs, editions, and rights ownership (territory, language).
  • Note registration status with the US Copyright Office (and equivalents abroad).

• Evidence of likely ingestion

  • Check dataset search tools that index common web-scraped corpora and book datasets.
  • Save credible screenshots/URLs and maintain a dated evidence file.

• Contracts and rights splits

  • For traditionally published works, review whether the publisher, you, or both hold relevant rights for claims and settlement proceeds.
  • Identify translation, anthology, or audio rights that may have different owners.

• Tax and payment readiness

  • Expect W-9/W-8 forms and potential 1099s for US taxpayers.
  • Decide whether payments should flow to an entity (LLC, publisher) or an individual.

• Counsel and representation

  • If you’re a large rightsholder, consult counsel to model expected class recovery versus individual litigation outcomes.
  • Small authors can often navigate class claims pro se, but legal clinics and guild resources can help with tricky chain-of-title questions.

How payouts in mega-fund cases typically work

While the final plan may differ, many class distributions follow a points-based system:

• Points assigned per work category (e.g., book-length works vs. short articles) and adjusted for factors like registration or sales proxies.
• Total fund minus fees, costs, and administration is divided by total approved points to derive a per-point value.
• Minimum payments and caps can apply to prevent de minimis checks or overconcentration.
• Uncashed amounts often roll to second distributions or cy pres charities aligned with class interests.

Key caveats

• A “claims-made” structure means unclaimed money doesn’t always revert to claimants; read the papers to see if there’s a floor or reversion.
• If fees are reduced by the court, remaining funds might increase the per-point value.

What the fee fight could change for you

Judges weigh fairness using multiple benchmarks:

• Percentage-of-fund vs. lodestar cross-check: The court may trim fees if the implied multiplier is outsized given risk and effort.
• Bluetooth-style red flags: Clear-sailing agreements or reversionary “kickers” can trigger tougher review.
• Distribution reality: Courts ask whether class members will actually receive meaningful cash, not just theoretical sums.

If the court lowers fees or tightens admin costs, your net recovery could rise. Conversely, if the judge requires narrower releases, some claims might be preserved for future action.

Comparison: staying in a class deal vs. suing individually

Staying in the class

• Timeline: Months to a couple of years for payment, depending on appeals.
• Cost: Little to none out-of-pocket; fees come from the fund.
• Outcome: Predictable but capped, with broad releases.

Suing individually

• Timeline: 2–5+ years, with uncertainty and appeal risk.
• Cost: Significant legal fees and discovery; potential contingency arrangements.
• Outcome: Potentially higher recovery and bespoke injunctive relief, but risk of zero.

Red flags and protections to watch in the final terms

Red flags

• Overbroad releases that include future, unrelated technologies without additional consideration.
• Reversion of large unclaimed funds to the defendant instead of a second distribution or cy pres aligned with creators.
• Onerous proof requirements that discourage claims (e.g., uploading full manuscripts).

Good signs

• Clear prospective commitments: training opt-outs, dataset transparency, and output filters that reduce regurgitation.
• Tiered compensation reflecting the higher value and risk of long-form works.
• Independent auditor or special master for disputes and audits.

Timeline: what happens next

• Additional briefing and revised proposals: Expect parties to file more detail on fees, allocation, and notice.
• New preliminary approval decision: Once satisfied, the court issues a schedule.
• Notice period opens: You’ll receive instructions on filing, opting out, or objecting.
• Fairness hearing: The court considers objections, may modify terms, then rules on final approval.
• Appeals window: Even after approval, objectors can appeal, which can delay distribution.

Frequently asked questions

What if I’m outside the US?

• Many US class actions include foreign members if the alleged conduct and forum are in the US. Watch the notice for inclusion rules and tax forms (W-8BEN).

Do I need to prove my work was ingested?

• Often you’ll attest under penalty of perjury and provide reasonable evidence if requested. Exact proof burdens vary; check the claim form when it’s released.

Can I both object and opt out?

• Not usually. If you opt out, you’re no longer part of the class and lack standing to object. You can object and stay in, then withdraw an objection if terms improve.

Will this affect my ability to license to AI companies later?

• The release may cover past and certain future uses by the defendant. It typically won’t bar you from licensing to other companies later. Read the release carefully.

What about outputs that mirror my text?

• Some settlements address output safeguards. Independently of the deal, you may still have claims against downstream misuse by third parties. The release scope is key.

How big could my payment be?

• It depends on the final allocation, number of claimants, and deductions for fees/costs. Mega-classes can produce modest per-work payments; large catalogs can still add up.

What if I miss the deadline?

• Courts sometimes accept late claims for good cause, but don’t count on it. Subscribe to counsel updates or guild alerts to avoid missing dates.

Bottom line

The judge’s delay is not a rejection; it’s a request for a cleaner, more balanced deal. Use the time to audit your catalog, gather evidence, and run the numbers on three paths: file a claim, opt out, or object. When revised papers arrive, focus on eligibility, allocation math, release scope, and fee size—those four lines will determine whether this settlement works for you.

Source & original reading: https://arstechnica.com/tech-policy/2026/05/authors-fight-for-higher-payouts-from-anthropics-1-5b-copyright-settlement/